Carving a niche for immunotherapy in ovarian cancer

por Gupta, Nitasha, Lampert, Erika, Lee, Jung-Min
Publicado 2021

Prevalence of Alzheimer’s Pathologic Endophenotypes in Asymptomatic and Mildly Impaired First-Degree Relatives

por Lampert, Erika J., Roy Choudhury, Kingshuk, Hostage, Christopher A., Petrella, Jeffrey R., Doraiswamy, P. Murali
Publicado 2013

Brain atrophy rates in first degree relatives at risk for Alzheimer's

por Lampert, Erika J., Roy Choudhury, Kingshuk, Hostage, Christopher A., Rathakrishnan, Bharath, Weiner, Michael, Petrella, Jeffrey R., Doraiswamy, P. Murali
Publicado 2014

Clinical outcomes of prexasertib monotherapy in recurrent BRCA wild-type high-grade serous ovarian cancer involve innate and adaptive immune responses

por Lampert, Erika J, Cimino-Mathews, Ashley, Lee, Joo Sang, Nair, Jayakumar, Lee, Min-Jung, Yuno, Akira, An, Daniel, Trepel, Jane B, Ruppin, Eytan, Lee, Jung-Min
Publicado 2020

Improved Framework for Tractography Reconstruction of the Optic Radiation

por Martínez-Heras, Eloy, Varriano, Federico, Prčkovska, Vesna, Laredo, Carlos, Andorrà, Magí, Martínez-Lapiscina, Elena H., Calvo, Anna, Lampert, Erika, Villoslada, Pablo, Saiz, Albert, Prats-Galino, Alberto, Llufriu, Sara
Publicado 2015

Phase I/Ib study of olaparib and carboplatin in heavily pretreated recurrent high-grade serous ovarian cancer at low genetic risk

por Lampert, Erika J., Hays, John L., Kohn, Elise C., Annunziata, Christina M., Minasian, Lori, Yu, Minshu, Gordon, Nicolas, Sissung, Tristan M., Chiou, Victoria L., Figg, William D., Houston, Nicole, Lee, Jung-Min
Publicado 2019

The multiple sclerosis visual pathway cohort: understanding neurodegeneration in MS

por Martínez-Lapiscina, Elena H, Fraga-Pumar, Elena, Gabilondo, Iñigo, Martínez-Heras, Eloy, Torres-Torres, Ruben, Ortiz-Pérez, Santiago, Llufriu, Sara, Tercero, Ana, Andorra, Magi, Roca, Marc Figueras, Lampert, Erika, Zubizarreta, Irati, Saiz, Albert, Sanchez-Dalmau, Bernardo, Villoslada, Pablo
Publicado 2014

Retinal and brain damage during multiple sclerosis course: inflammatory activity is a key factor in the first 5 years

por Pulido-Valdeolivas, Irene, Andorrà, Magí, Gómez-Andrés, David, Nakamura, Kunio, Alba-Arbalat, Salut, Lampert, Erika J., Zubizarreta, Irati, Llufriu, Sara, Martinez-Heras, Eloy, Solana, Elisabeth, Sola-Valls, Nuria, Sepulveda, María, Tercero-Uribe, Ana, Blanco, Yolanda, Camos-Carreras, Anna, Sanchez-Dalmau, Bernardo, Villoslada, Pablo, Saiz, Albert, Martinez-Lapiscina, Elena H.
Publicado 2020